HPLC Purity Testing for Research Peptides

Overview

Purity testing verifies that a research compound meets its stated specification. For peptides, high-performance liquid chromatography (HPLC) is the primary quantitative method.

HPLC Analysis

Reverse-phase HPLC (RP-HPLC) separates peptide species by hydrophobicity. The target peptide and its impurities (truncated sequences, deamidation products, oxidation products) elute at different retention times, producing a chromatogram.

Purity is typically reported as the area percent of the main peak relative to the total integrated area at a specified detection wavelength (commonly 214 nm or 220 nm for peptides).

Mass Spectrometry

HPLC quantifies purity; liquid chromatography-mass spectrometry (LC-MS) confirms identity by measuring the molecular weight of the main peak. Together, HPLC + MS provide both purity and identity assurance.

Interpretation

• A single dominant peak with ≥ 99% area suggests high purity.
• Minor peaks indicate impurities; their identity can be investigated by MS.
• Baseline resolution and symmetric peak shape indicate good chromatographic performance.

Acceptance Criteria

BlackBioLabs compounds are specified to a minimum purity of ≥ 99% by HPLC unless otherwise stated on the Certificate of Analysis.

References

• Standard analytical chemistry texts on RP-HPLC method development.

Research Use Notice: This material is provided for educational and laboratory research purposes only. It is not intended for human or veterinary use, diagnosis, or treatment. Always follow your institution's safety and handling protocols.

---

This article is for laboratory research and educational purposes only. It makes no medical, therapeutic, or diagnostic claims.